News

Late-stage clinical biopharmaceutical company, Liquidia Technologies focused on enhancing the performance of medicine by precisely engineering drug particles, today announced positive…
Read More...

Pixium Vision, Company committed to curating bionic vision systems ensuring revival of lost sight to patients, asserted the world’s first successful human implantation and activation of…
Read More...

COMPASS Trial results suggest affirmative Penumbra;s approach to effective thrombectomy approach for acute ischemic stroke as part of the ADAPT (A DirectAspiration, First Pass …
Read More...

European Patent Office grants Intent-to-Grant notice to biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant…
Read More...

European Medicines Agency asserted that Alnylam Pharmaceutical's application for Marketing Authorisation has been accepted for review of for patisiran, an investigational RNAi…
Read More...

Japan's Ministry of health, labor and Welfare extended marketing and manufacturing authorization for Regeneron's DUPIXENT for the treatment of atopic dermatitis in adults not curbed by…
Read More...

Chinese Center for Drug Evaluation has sanctioned an expansion of  expansion of the indications for Aggrastat for pharmaceutical company focused on commercializing patent-protected…
Read More...

Clinical-stage, biotherapeutics company, SillaJen committed to the development of oncolytic immunotherapy products for Cancer and ABL Europe company providing dedicated viral vector GMP…
Read More...

Ligand Pharmaceuticals asserted that it has forayed into a worldwide OmniAb platform license agreement with Ferring Pharmaceuticals. As per the terms of the agreement, Ferring…
Read More...

Astellas Pharma confirmed acquisition of MitoBridge. Astellas shelled out $225 million to acquire 100% of the equity in Mitobridge. The acquisition sets the tone for Astellas's further…
Read More...

WCG confirms the appointment of Shannon Bledsoe as its Executive Director. She will be responsible for overall organizational growth and strategic direction and overseeing the quality…
Read More...

Swedish Orphan Biovitrum AB confirmed FDA's acceptance of the investigational new drug application for the drug candidate SOBI003 along with granting Fast track status to it. SOBI003 is…
Read More...

Evofem Biosciences committed to the development and commercialization of women's healthcare products asserted the enrollment of its first patient in  Phase 2b/3 clinical trial…
Read More...

ProMIS Neurosciences committed to the discovery and development of precision treatments for neurodegenerative diseases, announced further results of its previously announced and ongoing…
Read More...

Biomarck Pharmaceuticals affirmed initiation of Phase 2 Clinical study in advanced NSCLC.  The study is meant to compare  standard of Care Therapy alone to SOC plus BIO-11006. BIO-11006…
Read More...

U.S FDA grants clearance for QIAGEN's ipsogen JAK2 RGQ PCR Kit for ascertaining myeloproliferative neoplasms (MPNs), which are a group of cancers in which immature blood cells in the…
Read More...

Surefire Medical affirmed the appointment of Mary T. Szela as its CEO, President and a member of the company's Board Of Directors. James Chomas PhD precedes Szela who served as…
Read More...

JSR life sciences of the JSR corporation confirmed the appointment of Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International with effect immediately.…
Read More...

Puma Biotechnology asserted that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has conveyed a negative trend vote after discussions…
Read More...

Cerus Corporation asserted successful achievement of primary efficacy and safety endpoints in the Company's Phase 3 transfusion study of Chronic anaemia assessing INTERCEPT-treated Red…
Read More...